Vertex Pharmaceuticals Inc / Ma SEC filings VRTX

Vertex Pharmaceuticals Inc / Ma has 1,002 filings in SEC EDGAR's recent list, going back to Jun 3, 2020. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.

Vertex Pharmaceuticals Inc / Ma SEC filings
Form Description Filed Period
144 Notice of proposed sale Nov 6, 2026 —
4 Insider transaction Oct 22, 2026 Oct 20, 2026
3 Initial insider ownership Oct 22, 2026 Oct 20, 2026
4 Insider transaction Oct 19, 2026 Oct 15, 2026
4 Insider transaction Oct 19, 2026 Oct 15, 2026
4 Insider transaction Sep 10, 2026 Sep 8, 2026
3 Initial insider ownership Sep 10, 2026 Sep 8, 2026
4 Insider transaction Sep 1, 2026 Aug 28, 2026
4 Insider transaction Aug 31, 2026 Aug 27, 2026
144 Notice of proposed sale Aug 27, 2026 —
4 Insider transaction Jul 23, 2026 Jul 21, 2026
4 Insider transaction Jul 23, 2026 Jul 21, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
144 Notice of proposed sale Jul 2, 2026 —
144 Notice of proposed sale Jul 2, 2026 —
144 Notice of proposed sale Jul 1, 2026 —
4 Insider transaction Jun 30, 2026 Jun 26, 2026
144 Notice of proposed sale Jun 26, 2026 —
4 Insider transaction Jun 23, 2026 Jun 18, 2026
144 Notice of proposed sale Jun 18, 2026 —
4 Insider transaction Jun 17, 2026 Jun 15, 2026
144 Notice of proposed sale Jun 15, 2026 —
4 Insider transaction Jun 9, 2026 Jun 5, 2026
144 Notice of proposed sale Jun 5, 2026 —
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 2, 2026 May 29, 2026
144 Notice of proposed sale Jun 1, 2026 —
144 Notice of proposed sale May 29, 2026 —
4 Insider transaction May 19, 2026 May 15, 2026
4 Insider transaction May 19, 2026 May 15, 2026
144 Notice of proposed sale May 15, 2026 —
144 Notice of proposed sale May 15, 2026 —
4 Insider transaction May 14, 2026 May 12, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2026 —
144 Notice of proposed sale May 12, 2026 —
144 Notice of proposed sale May 6, 2026 —
4 Insider transaction May 5, 2026 May 1, 2026
4 Insider transaction May 5, 2026 May 1, 2026
4 Insider transaction May 5, 2026 May 1, 2026
4 Insider transaction May 5, 2026 May 1, 2026
4 Insider transaction May 5, 2026 May 1, 2026
4 Insider transaction May 5, 2026 May 1, 2026
4 Insider transaction May 5, 2026 May 1, 2026
4 Insider transaction May 5, 2026 May 1, 2026
4 Insider transaction May 5, 2026 May 1, 2026
4 Insider transaction May 5, 2026 May 1, 2026
144 Notice of proposed sale May 4, 2026 —
144 Notice of proposed sale May 1, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 30, 2026 —
4 Insider transaction Apr 17, 2026 Apr 15, 2026
4 Insider transaction Apr 17, 2026 Apr 15, 2026
4 Insider transaction Apr 17, 2026 Apr 15, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
144 Notice of proposed sale Apr 1, 2026 —
4 Insider transaction Mar 31, 2026 Mar 27, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
144 Notice of proposed sale Mar 27, 2026 —
4 Insider transaction Mar 17, 2026 Mar 13, 2026
4 Insider transaction Mar 13, 2026 Mar 11, 2026
144 Notice of proposed sale Mar 13, 2026 —
144 Notice of proposed sale Mar 11, 2026 —
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
144 Notice of proposed sale Mar 4, 2026 —
3 Initial insider ownership Mar 3, 2026 Mar 1, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
144 Notice of proposed sale Mar 2, 2026 —
4 Insider transaction Mar 2, 2026 Feb 26, 2026
144 Notice of proposed sale Feb 27, 2026 —
144 Notice of proposed sale Feb 27, 2026 —
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
144 Notice of proposed sale Feb 25, 2026 —
144 Notice of proposed sale Feb 25, 2026 —
144 Notice of proposed sale Feb 25, 2026 —
144 Notice of proposed sale Feb 25, 2026 —
144 Notice of proposed sale Feb 25, 2026 —
144 Notice of proposed sale Feb 25, 2026 —
4 Insider transaction Feb 23, 2026 Feb 19, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
144 Notice of proposed sale Feb 19, 2026 —
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
144 Notice of proposed sale Feb 18, 2026 —
144 Notice of proposed sale Feb 18, 2026 —
144 Notice of proposed sale Feb 18, 2026 —
144 Notice of proposed sale Feb 18, 2026 —
144 Notice of proposed sale Feb 17, 2026 —
144 Notice of proposed sale Feb 17, 2026 —
144 Notice of proposed sale Feb 17, 2026 —
144 Notice of proposed sale Feb 17, 2026 —
144 Notice of proposed sale Feb 13, 2026 —
144 Notice of proposed sale Feb 13, 2026 —
144 Notice of proposed sale Feb 13, 2026 —
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Feb 12, 2026 Feb 10, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2026 —
144 Notice of proposed sale Feb 11, 2026 —
144 Notice of proposed sale Feb 11, 2026 —
144 Notice of proposed sale Feb 11, 2026 —
144 Notice of proposed sale Feb 11, 2026 —
3 Initial insider ownership Feb 3, 2026 Feb 1, 2026
4 Insider transaction Jan 26, 2026 Jan 22, 2026
4 Insider transaction Jan 26, 2026 Jan 22, 2026
4 Insider transaction Jan 26, 2026 Jan 22, 2026
4 Insider transaction Jan 26, 2026 Jan 22, 2026
4 Insider transaction Jan 26, 2026 Jan 22, 2026
4 Insider transaction Jan 26, 2026 Jan 22, 2026
4 Insider transaction Jan 26, 2026 Jan 22, 2026
4 Insider transaction Jan 26, 2026 Jan 22, 2026
4 Insider transaction Jan 26, 2026 Jan 22, 2026
4 Insider transaction Jan 26, 2026 Jan 22, 2026
4 Insider transaction Jan 26, 2026 Jan 22, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 9, 2026 Jan 7, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
144 Notice of proposed sale Jan 7, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
4 Insider transaction Dec 5, 2025 Dec 3, 2025
4 Insider transaction Dec 5, 2025 Dec 3, 2025
4 Insider transaction Dec 5, 2025 Dec 3, 2025
4 Insider transaction Dec 5, 2025 Dec 3, 2025
144 Notice of proposed sale Dec 3, 2025 —
144 Notice of proposed sale Dec 3, 2025 —
144 Notice of proposed sale Dec 3, 2025 —
144 Notice of proposed sale Dec 3, 2025 —
144 Notice of proposed sale Dec 3, 2025 —
4 Insider transaction Nov 20, 2025 Nov 19, 2025
144 Notice of proposed sale Nov 20, 2025 —
4 Insider transaction Nov 19, 2025 Nov 17, 2025
4 Insider transaction Nov 17, 2025 Nov 13, 2025
144 Notice of proposed sale Nov 17, 2025 —
144 Notice of proposed sale Nov 14, 2025 —
144 Notice of proposed sale Nov 13, 2025 —
4 Insider transaction Oct 17, 2025 Oct 15, 2025
4 Insider transaction Oct 17, 2025 Oct 15, 2025
4 Insider transaction Oct 3, 2025 Oct 1, 2025
144 Notice of proposed sale Oct 2, 2025 —
4 Insider transaction Aug 29, 2025 Aug 27, 2025
144 Notice of proposed sale Aug 27, 2025 —
4 Insider transaction Aug 7, 2025 Aug 6, 2025
4 Insider transaction Aug 7, 2025 Aug 6, 2025
4 Insider transaction Jul 17, 2025 Jul 15, 2025
4 Insider transaction Jul 17, 2025 Jul 15, 2025
3 Initial insider ownership Jul 2, 2025 Jul 1, 2025
4 Insider transaction Jul 2, 2025 Jul 1, 2025
144 Notice of proposed sale May 21, 2025 —
144 Notice of proposed sale May 21, 2025 —
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 15, 2025 May 13, 2025
144 Notice of proposed sale May 15, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 13, 2025 —
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
VRTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
MA
Headquarters
Boston, MA
SEC filer status
Large accelerated filer
SEC CIK
875320

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.